The “Cell Line Development Market by Product (Equipment, Media and Reagents), by Source, by type, by Application ( Bioproduction, Tissue Engineering & Regenerative medicine, Toxicity Testing, Research, Drug Discovery) - Analysis & Global Forecast to 2019” analyzes and studies the major market drivers, threats, opportunities, and challenges.
Browse 114 market data tables and 64 figures spread through 225 pages and in-depth TOC on “Cell Line Development Market
http://www.marketsandmarkets.com/Market-Reports/cell-line-development-market-152900899.html
Early buyers will receive 10% customization on reports.
The global cell line development market is segmented on the basis of products, type of cell lines, source of cell lines, applications, and geographies.
Download PDF Brochure @ http://www.marketsandmarkets.com/pdfdownload.asp?id=152900899
The cell line development market, by type is further segmented into primary cell lines, continuous cell lines, hybridomas, and recombinant cell lines. Recombinant cell lines are expected to account for a major share of the cell line development market in 2014.
Bioproduction, tissue engineering and regenerative medicine, toxicity testing, research, and drug discovery are the key application areas of cell lines. Bioproduction is expected to account for a major share among the application areas in the cell line development market.
Inquiry of this report @ http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=152900899
On the basis of geography, the market is divided into North America, Europe, Asia, and Rest of the World (RoW). Rest of the World comprises of Latin America, Pacific countries, and Africa. North America holds the largest in the cell line development market, followed by Europe and Asia. However, the Asian market is slated to grow at the highest CAGR in the coming five years and serves as a revenue pocket for cell line manufacturers.
Some of the major players in the global cell line development market include American Type Culture Collection (ATCC) (U.S.), Lonza Group AG (Switzerland), Thermo Fisher Scientific, Inc. (U.S.), GE Healthcare (U.K.), Sigma-Aldrich Corporation (U.S.), Selexis SA (Switzerland), European Collection of Cell Cultures (ECACC) (U.K.), Corning, Inc. (U.S.), Wuxi App Tec, Inc. (China), and Sartorious AG (Germany).